Ledger.Open graph →
SEC Form D · Amendment · filed November 9, 2016

Metacrine, Inc

Offering
$37.8M
Sold
$37.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Ken Song · San Diego, CAExec · DirectorAmir Nashat · San Diego, CADirectorRonald Evans · San Diego, CADirectorRichard Heyman · San Diego, CADirectorKristina Burow · San Diego, CADirectorTrisha Millican · San Diego, CAExecRobert Adelman · San Diego, CADirectorEric Stewart · Robinson, ILExec · DirectorAlaina Danley · Grand Cayman, Cayman IslandsDirectorWilliams M. Clark · Austin, TXDirectorJerrold C. Miller · DENVER, COExecMatthew Ginsberg · Eugene, ORDirectorLilly J. Farahnakian · Chicago, ILDirectorDennis Capovilla · Eugene, ORDirectorJames Deters · DENVER, CODirectorLawrence C. Mandes · DENVER, CODirectorJ. D. Duebendorfer · New York, NYExecMurray Markiles · Sherman Oaks, CADirectorMichael Hylander · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗